key: cord-0993339-x30b1rwj authors: Lebret, Marius; Fresnel, Emeline; Prieur, Guillaume; Quieffin, Jean; Dupuis, Johan; Lamia, Bouchra; Combret, Yann; Medrinal, Clément title: Se requieren altos índices de flujo de O¬2 para alcanzar una FiO2 aceptable en los pacientes con covid-19 tratados con CPAP: un estudio experimental basado en la clínica date: 2021-04-26 journal: Arch Bronconeumol DOI: 10.1016/j.arbres.2021.04.018 sha: e26786740bc296de788e2c189ed402e03e1821f6 doc_id: 993339 cord_uid: x30b1rwj nan During the Covid-19 pandemic, a lack of ventilatory equipment in intensive care units (ICU), or patient comorbidities meant that some patients received non invasive, continuous positive airway pressure (CPAP), with the highest fraction of inspired oxygen (FiO2) as a ceiling treatment [1] [2] [3] . In Le Havre hospital (France), between September and December 2020, around 30 patients were treated with bilevel home devices in CPAP mode using vented oronasal masks. In contrast with bench studies that reported high FiO2 with oxygen flow rates < 30L/min in optimal experimental conditions (i.e., low minute ventilation, good pulmonary compliance and no leakage) [4, 5] , many patients required O2 flow rates > 70L/min to maintain oxygen saturation (SpO2) ≥ 90%. We hypothesised that due to the high respiratory demand of patients with severe Covid-19, a high O2 flow rate would be required to reach adequate pressure levels with CPAP, thereby substantially increasing the oxygen flow rate needed to achieve a high FiO2. We carried out a bench study to measure the oxygen flow rates needed to reach high FiO2 levels, using a pulmonary model that reproduced the characteristics of patients with severe Covid-19. First, we extracted clinical data from 10 consecutive patients who were included in an ongoing clinical trial (EURO-CPAP CT2220141 approved by our institutional review board) from the CPAP built-in software. This case series is presented for descriptive purposes to illustrate our hypothesis. Then, we performed several bench experiments. We used a CPAP device (AirSense 10 AutoSet, ResMed, San Diego, CA, USA) set at 10 cmH2O, connected to an artificial lung (ASL 5000, Ingmar Medical, Pittsburgh, PA, USA). A low-resistance antibacterial filter (Clear-Guard, Intersurgical, Wokingham, UK), an oxygen inlet connector, a 15 mm single limb circuit, a Whisper Swivel II Exhalation port (Philips Respironics, Murrysville, PA, USA) that simulated intentional leaks, and the artificial lung were placed in series and connected to the CPAP device. A standard 4-mm diameter leak port was placed between the exhalation port and the artificial lung to mimic unintentional leakage. Oxygen was delivered into the system using two O2 flow meters (EASY MED-O2, Air Liquide Healthcare, Paris, France) that could both deliver up to 50 L/min. Three different mechanical lung conditions were simulated by modulating the resistance (R) and the compliance (C) of the artificial lung, corresponding to the following experimental models: A. Normal: R=5 cmH2O/l.s and C=60 ml/cmH2O B. Restrictive: R=5 cmH2O/l.s and C=30 ml/cmH2O. C. Normal with by-pass leak using a T-connector as recommended to reduce the risk of droplet aerosolization [6] . Table 1 . Six patients needed O2 flow rates ≥50L/min to maintain SpO2>90%. Minimum O2 flow rate was 15 L/min. All patients had severe infection (i.e., PaO2/FiO2 ratio ≤150 at CPAP initiation). Figure 1 shows the relationship between the O2 flow rate delivered and the resulting FiO2 in the simulation. Without unintentional leaks, a flow rate of at least 30 L/min was necessary to reach FiO2 > 95%. FiO2 differed significantly for each respiratory rate at each O2 flow rate with and without unintentional leaks (p<0.001). With unintentional leaks, O2 flow rates of up to 80 l/min were required to reach 100% FiO2 (Figures 1A, 1B and 1C ). The results of this experimental bench study confirmed our clinical observation that high O2 flow rates are required to achieve a high FiO2 in patients with severe Covid-19 using CPAP and vented masks. An O2 flow rate of at least 30 L/min, and up to 80 L/min, was required to achieve 100% FiO2 for all three experimental models. Reduced compliance and unintentional leakage dramatically reduced FiO2. The arbitrary compliance of 30 ml/cmH2O used in model B is similar to that of patients with severe COVID-19 [12] . Such a low level of compliance would reduce the FiO2 with home CPAP and a vented mask, further confirming the need for high O2 flow rates. In our clinical cohort, three patients required an O2 flow rate above 80L/min: this very high rate causes two concerns. Firstly, we did not know the lung compliance of these patients. Secondly, the O2 flow rate required to achieve a given FiO2 is likely to be underestimated with the experimental model compared to the clinical situation, since no gas exchange occurs with an artificial lung. For instance, in a patient, with a 21% FiO2, the partial pressure of O2 in the inspired air will be 160 mm Hg, while in the expired air (at sea level) it will be 120 mm Hg due to oxygen absorption. Thus, in in-vivo conditions even higher O2 flows than those reported in this study may be required [13] . Another important point is that many teams use helmets to ventilate patients with Covid-19 [2, 14] . Helmets could be more advantageous than oronasal masks because of the lower rate of unintentional leakage; this would allow lower oxygen flow rates to be used to achieve sufficient FiO2 levels for patients with severe hypoxemia. Studies have shown that patients who cannot be intubated require a high FiO2 to maintain their SpO2 above 92% [3, 15] , and that poor oxygenation is strongly associated with mortality [3, 16] . Our study provides valuable data to guide clinicians in the use of O2 when using home CPAP in patients with severe Covid-19 who cannot be intubated. The results showed that these patients can be successfully treated with home CPAP devices, or NIV devices in CPAP mode, with vented masks, if a high O2 flow rate is provided. However, close monitoring of unintentional leaks is crucial to ensure a sufficient FiO2 for the treatment of severe hypoxemia in these patients. Dose-response relationship between oxygen (O2) flow rates delivered into the circuit, and fraction of inspired oxygen (FiO2) as a function of respiratory rate, presence/absence of non-intentional leakage, lung mechanics and leak port locations. Each Plot represent the mean FiO2 of the 10 cycles analysed. For each FiO2, the standard deviation was systematically below 0.3 and is therefore not represented on the graph. Panel A displays the results for the conventional intentional leak model, in which the unintentional leakage port was placed in series between the exhalation valve (intentional leak port) and the ASL 5000. Panel B displays the results for the same model as in panel A, but with restrictive lung mechanics. Panel C displays the results for by-pass leakage ports using an antibacterial filter between the ASL 5000 and both intentional and nonintentional leak ports. The blue lines represent the relationship between O2 flow and FiO2 without unintentional leaks, and the green lines represent the relationship between O2 flow and Fi2O with unintentional leaks. Continuous Positive Airway Pressure (CPAP) facemask ventilation is an easy and cheap option to manage a massive influx of patients presenting acute respiratory failure during the SARS-CoV-2 outbreak: A retrospective cohort study Helmet CPAP treatment in patients with COVID-19 pneumonia: a multicentre cohort study Noninvasive Ventilatory Support of COVID-19 Patients Outside the Intensive Care Units (WARd-COVID) Laboratory performance of oronasal CPAP and adapted snorkel masks to entrain oxygen and CPAP Mechanical Ventilators for Non-Invasive Ventilation: Principles of Technology and Science -Nova Science Publishers Respiratory support in patients with COVID-19 (outside intensive care unit). A position paper of the Respiratory Support and Chronic Care Group of the French Society of Respiratory Diseases Statement on Respiratory Muscle Testing Realistic human muscle pressure for driving a mechanical lung Comparison of esophageal, tracheal, and mouth occlusion pressure in patients with chronic obstructive pulmonary disease during acute respiratory failure Mouth occlusion pressure, CO2 response and hypercapnia in severe chronic obstructive pulmonary disease Respiratory muscle strength and control of ventilation in patients with neuromuscular disease Ventilatory Mechanics in Early vs Late Intubation in a Cohort of Coronavirus Disease 2019 Patients With ARDS: A Single Center's Experience Review Series: Lung function made easy: Assessing gas exchange Helmet CPAP to Treat Acute Hypoxemic Respiratory Failure in Patients with COVID-19: A Management Strategy Proposal Outcomes of COVID-19 patients treated with continuous positive airway pressure outside the intensive care unit Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study The authors would like to thank Asten Santé for providing funding the trial. The authors would also like to thank Johanna Robertson for English editing. Dr. Marius Lebret is the guarantor of the content of the manuscript, including the data and analysis. The authors would like to thank Asten Santé for providing funding the trial. The authors would also like to thank Johanna Robertson for English editing.